Cargando…
Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma
Background: The role of ferroptosis in esophageal squamous cell carcinoma (ESCC) is still unclear. Methods: The association of iron metabolism and ferroptosis-related genes with the prognosis, copy number variation (CNV), TMB, and immune cell infiltration of ESCC was explored using data from the GEO...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965120/ https://www.ncbi.nlm.nih.gov/pubmed/35371305 http://dx.doi.org/10.7150/jca.68568 |
_version_ | 1784678364915695616 |
---|---|
author | Zhao, Mengnan Li, Ming Zheng, Yuansheng Hu, Zhengyang Liang, Jiaqi Bi, Guoshu Bian, Yunyi Sui, Qihai Zhan, Cheng Lin, Miao Wang, Qun |
author_facet | Zhao, Mengnan Li, Ming Zheng, Yuansheng Hu, Zhengyang Liang, Jiaqi Bi, Guoshu Bian, Yunyi Sui, Qihai Zhan, Cheng Lin, Miao Wang, Qun |
author_sort | Zhao, Mengnan |
collection | PubMed |
description | Background: The role of ferroptosis in esophageal squamous cell carcinoma (ESCC) is still unclear. Methods: The association of iron metabolism and ferroptosis-related genes with the prognosis, copy number variation (CNV), TMB, and immune cell infiltration of ESCC was explored using data from the GEO and TCGA database and validated by immunofluorescence in 112 ESCC patients from our center. The potential anti-cancer drugs and compounds from the GDSC and the Connectivity Map database were also screened. Results: A total of 117 iron metabolism and ferroptosis-related genes were identified. We found the expressions of PRNP, SLC3A2, SLC39A8, and SLC39A14 negatively related to the prognosis of ESCC patients, while ATP6V0A1 and LCN2 were opposite, which was validated in 112 ESCC samples from our center. And a prognostic signature was constructed based on their expressions and Cox regression coefficient (β). The low-score group exhibited a significantly worse OS. Besides, analysis of 179 ESCC samples from GSE53625 revealed that patients of poorly differentiation, more than 60 years, T4 stage, advanced N stage, advanced stage, and adjuvant therapy also exhibited a significantly shorter OS, based on which a nomogram to predict the OS was established. Moreover, the low-score group exhibited significantly higher CNV and TMB and more frequent mutations of TP53, MUC16, and NOTCH1. Higher proportion of Macrophages M2, and lower proportion of T cells follicular helper were observed in the low-score group. We discovered that AZD7762, Sunitinib, Cytarabine, Docetaxel, Vinblastine, and Elesclomol exhibited lower IC50 in the low-score group. And 20 potential compounds were identified from the CMap database. Conclusions: Six iron metabolism and ferroptosis-related genes were associated with the prognosis, CNV, TMB, and immune cell infiltration of ESCC. Some potential anti-cancer drugs and compounds may be helpful for OS. |
format | Online Article Text |
id | pubmed-8965120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-89651202022-04-01 Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma Zhao, Mengnan Li, Ming Zheng, Yuansheng Hu, Zhengyang Liang, Jiaqi Bi, Guoshu Bian, Yunyi Sui, Qihai Zhan, Cheng Lin, Miao Wang, Qun J Cancer Research Paper Background: The role of ferroptosis in esophageal squamous cell carcinoma (ESCC) is still unclear. Methods: The association of iron metabolism and ferroptosis-related genes with the prognosis, copy number variation (CNV), TMB, and immune cell infiltration of ESCC was explored using data from the GEO and TCGA database and validated by immunofluorescence in 112 ESCC patients from our center. The potential anti-cancer drugs and compounds from the GDSC and the Connectivity Map database were also screened. Results: A total of 117 iron metabolism and ferroptosis-related genes were identified. We found the expressions of PRNP, SLC3A2, SLC39A8, and SLC39A14 negatively related to the prognosis of ESCC patients, while ATP6V0A1 and LCN2 were opposite, which was validated in 112 ESCC samples from our center. And a prognostic signature was constructed based on their expressions and Cox regression coefficient (β). The low-score group exhibited a significantly worse OS. Besides, analysis of 179 ESCC samples from GSE53625 revealed that patients of poorly differentiation, more than 60 years, T4 stage, advanced N stage, advanced stage, and adjuvant therapy also exhibited a significantly shorter OS, based on which a nomogram to predict the OS was established. Moreover, the low-score group exhibited significantly higher CNV and TMB and more frequent mutations of TP53, MUC16, and NOTCH1. Higher proportion of Macrophages M2, and lower proportion of T cells follicular helper were observed in the low-score group. We discovered that AZD7762, Sunitinib, Cytarabine, Docetaxel, Vinblastine, and Elesclomol exhibited lower IC50 in the low-score group. And 20 potential compounds were identified from the CMap database. Conclusions: Six iron metabolism and ferroptosis-related genes were associated with the prognosis, CNV, TMB, and immune cell infiltration of ESCC. Some potential anti-cancer drugs and compounds may be helpful for OS. Ivyspring International Publisher 2022-03-06 /pmc/articles/PMC8965120/ /pubmed/35371305 http://dx.doi.org/10.7150/jca.68568 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Zhao, Mengnan Li, Ming Zheng, Yuansheng Hu, Zhengyang Liang, Jiaqi Bi, Guoshu Bian, Yunyi Sui, Qihai Zhan, Cheng Lin, Miao Wang, Qun Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma |
title | Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma |
title_full | Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma |
title_fullStr | Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma |
title_full_unstemmed | Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma |
title_short | Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma |
title_sort | identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965120/ https://www.ncbi.nlm.nih.gov/pubmed/35371305 http://dx.doi.org/10.7150/jca.68568 |
work_keys_str_mv | AT zhaomengnan identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma AT liming identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma AT zhengyuansheng identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma AT huzhengyang identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma AT liangjiaqi identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma AT biguoshu identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma AT bianyunyi identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma AT suiqihai identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma AT zhancheng identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma AT linmiao identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma AT wangqun identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma |